Literature DB >> 20930284

MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants.

Shufen Chen1, Kirk Townsend, Terry E Goldberg, Peter Davies, Concepcion Conejero-Goldberg.   

Abstract

Tau aggregation in neurofibrillary tangles is a pathological hallmark in tauopathies including Alzheimer's disease (AD). The predominant aggregation of certain MAPT (tau gene) isoforms, either the 4-repeat (4R tau) or the 3-repeat (3R tau) isoform has been widely described in tauopathies. Alterations of the 4R tau to 3R tau ratio may be a key for tau-related neurodegeneration. To study the biological consequences in expression between tau splicing isoforms 4R and 3R, we analyzed the main neurobiological effects of inclusion of the repeat region coded by exon 10 in MAPT. We compared the transcriptional profiles of the 4R tau isoforms to 3R tau isoforms using whole-genome gene expression profiling microarrays using human neuroblastoma SH-SY5Y cell lines overexpressing either human 4R tau or 3R tau isoforms. We identified 68 transcripts that differed significantly (at p < 0.001) between 4R and 3R isoforms as conditioned on a second variant, the so-called 2N inclusion. We extended these findings in a 2 × 2 ANOVA to examine interaction effects of these variants. Transcripts involved in embryonic development were downregulated when exon 10 was present, while transcripts related to outgrowth of neurites were generally upregulated. An important pathway implicated in AD also differed between the 3R and 4R cell lines, Wnt signaling. These studies demonstrate expression differences between MAPT isoforms 4R tau and 3R tau due to the inclusion/exclusion of the repeat region coded for by exon 10. Our data add to complex findings on the role of 3R/4R in normal and abnormal neuronal function and highlight several molecular mechanisms that might drive neurodegeneration, or perhaps, set the stage for it.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930284      PMCID: PMC3322427          DOI: 10.3233/JAD-2010-101155

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  42 in total

1.  Overexpression of the protein phosphatase 2A regulatory subunit Bgamma promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade.

Authors:  Stefan Strack
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

2.  Testing association of a pathway with survival using gene expression data.

Authors:  Jelle J Goeman; Jan Oosting; Anne-Marie Cleton-Jansen; Jakob K Anninga; Hans C van Houwelingen
Journal:  Bioinformatics       Date:  2005-01-18       Impact factor: 6.937

3.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

5.  In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury.

Authors:  Simone Di Giovanni; Andrea De Biase; Alexander Yakovlev; Tom Finn; Jeanette Beers; Eric P Hoffman; Alan I Faden
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

6.  Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.

Authors:  J C Reubi; M Gugger; B Waser; J C Schaer
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

7.  Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho.

Authors:  G Tigyi; D J Fischer; A Sebök; C Yang; D L Dyer; R Miledi
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

8.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

9.  Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice.

Authors:  Kristina Sennvik; Karin Boekhoorn; Reena Lasrado; Dick Terwel; Steven Verhaeghe; Hubert Korr; Christoph Schmitz; Takami Tomiyama; Hiroshi Mori; Harm Krugers; Marian Joels; Ger J A Ramakers; Paul J Lucassen; Fred Van Leuven
Journal:  FASEB J       Date:  2007-03-06       Impact factor: 5.191

10.  Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  J Neurochem       Date:  2006-03       Impact factor: 5.372

View more
  21 in total

1.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

Review 2.  Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects.

Authors:  Glenda Halliday; Eileen H Bigio; Nigel J Cairns; Manuela Neumann; Ian R A Mackenzie; David M A Mann
Journal:  Acta Neuropathol       Date:  2012-08-10       Impact factor: 17.088

3.  Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing.

Authors:  Lorna W Harries; Dena Hernandez; William Henley; Andrew R Wood; Alice C Holly; Rachel M Bradley-Smith; Hanieh Yaghootkar; Ambarish Dutta; Anna Murray; Timothy M Frayling; Jack M Guralnik; Stefania Bandinelli; Andrew Singleton; Luigi Ferrucci; David Melzer
Journal:  Aging Cell       Date:  2011-07-19       Impact factor: 9.304

Review 4.  Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.

Authors:  Surajit Sarkar
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

5.  Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.

Authors:  Yutaro Komuro; Guixiang Xu; Kiran Bhaskar; Bruce T Lamb
Journal:  Neurobiol Aging       Date:  2015-03-09       Impact factor: 4.673

6.  Tau-dependent suppression of adult neurogenesis in the stressed hippocampus.

Authors:  C Dioli; P Patrício; R Trindade; L G Pinto; J M Silva; M Morais; E Ferreiro; S Borges; A Mateus-Pinheiro; A J Rodrigues; N Sousa; J M Bessa; L Pinto; I Sotiropoulos
Journal:  Mol Psychiatry       Date:  2017-05-30       Impact factor: 15.992

Review 7.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

8.  Association of Parkinson's Disease GWAS-Linked Loci with Alzheimer's Disease in Han Chinese.

Authors:  Xi-Chen Zhu; Lei Cao; Meng-Shan Tan; Teng Jiang; Hui-Fu Wang; Huan Lu; Chen-Chen Tan; Wei Zhang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-06       Impact factor: 5.590

9.  Lessons from tau-deficient mice.

Authors:  Yazi D Ke; Alexandra K Suchowerska; Julia van der Hoven; Dineeka M De Silva; Christopher W Wu; Janet van Eersel; Arne Ittner; Lars M Ittner
Journal:  Int J Alzheimers Dis       Date:  2012-06-06

Review 10.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.